Monashee Investment Management’s BioAmber Inc. BIOA.WS Stock Holding History

Monashee Investment Management’s Portfolio BIOA.WS Stock Details BIOA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-150,000	Closed	-$43.6K	–	82
2016 Q4	$105K	Buy	+150,000	New	+$69.6K	0.05%	81
2016 Q3	–	Hold	0	–	–	–	84
2016 Q2	–	Hold	0	–	–	–	55
2016 Q1	–	Sell	-150,000	Closed	-$224K	–	34
2015 Q4	$212K	Hold	150,000	–	–	0.42%	25
2015 Q3	$267K	Buy	+150,000	New	+$282K	1.84%	10
2015 Q2	–	Sell	-150,000	Closed	-$295K	–	65
2015 Q1	$239K	Buy	+150,000	New	+$248K	0.15%	66

Other funds holding BIOA.WS

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

ACPU

Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

KJHP

K.J. Harrison & Partners Toronto, Ontario, Canada $608M AUM 45.31% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

VOAM

Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Monashee Investment Management's BIOA.WS Position: Q1 2017 in Review

Monashee Investment Management sold out of BioAmber Inc. (BIOA.WS) in Q1 2017, closing a stake of 150,000 shares — an estimated $43.6K sold.

Monashee Investment Management first reported a position in BIOA.WS in Q1 2015 and held it in 4 quarters. The position peaked at $267K in Q3 2015. 12 funds tracked by Wall St. Rank hold BIOA.WS as of Q1 2017.

Monashee Investment Management reported no remaining BioAmber Inc. position as of Q1 2017 after selling out during the quarter.
Monashee Investment Management sold 150,000 BioAmber Inc. shares in Q1 2017, an estimated $43.6K.
Monashee Investment Management first reported a position in BioAmber Inc. in Q1 2015 and held it in 4 quarters.
Monashee Investment Management's BioAmber Inc. position peaked at $267K in Q3 2015.
12 funds tracked by Wall St. Rank held BioAmber Inc. as of Q1 2017.

Based on Monashee Investment Management's 13F filing for Q1 2017, filed 12 May 2017.